Zig Lang
Dr. Lang is the Vice President and Head of International Medical Affairs and Oncology Clinical Development Asia-Pacific at Gilead Sciences. In this role, Zig oversees the Medical Affairs teams in countries and regions outsides of the US and Europe. He also leads the Oncology Clinical Development in the Asia-Pacific region.
Prior to coming to Gilead Sciences, Zig worked in Bayer’s Global Medical Affairs and Pharmacovigilance in the US and China. Zig has over 23 years of pharmaceutical industry experiences ranging from early and late stage clinical development to medical affairs. Zig held positions with increasing responsibilities at Bayer, Endo Pharmaceuticals, Johnson and Johnson, Wyeth and Novo Nordisk. Zig is a board-certified oncologist and hematologist in the US. He received his medical education at the Fourth Military Medical University in Xi’an and PhD in Biochemistry at Rush University in Chicago.
Rahul Mandlik
Dr. Rahul Mandlik is currently General Manager, Medical at Shalina Healthcare, based in the corporate office of Shalina group at Dubai, UAE. He has studied Pharmacology with Masters and PhD in Pharmacology and Toxicology from India.
Rahul has a diverse experience in areas such as medical training, patient engagement, real-world setting studies, clinical research, medical communication and publications, product launches, new product planning, medical events, etc. On his career path, he’s had opportunity to work in wide-range of therapeutic segments namely cardiology, diabetes, infective disorders, pain, gastroenterology, orthopedic, gynecology, neurology, psychiatry, dermatology and nutraceuticals.
Rahul started his professional pathway with medical services of Vitabiotics, Ltd. He worked in Torrent Pharmaceuticals for eight years in medical services on various business units within the organization.
